VRTX Stock | | | USD 468.13 3.57 0.77% |
Vertex Pharmaceuticals financial indicator trend analysis is much more than just breaking down Vertex Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vertex Pharmaceuticals is a good investment. Please check the relationship between Vertex Pharmaceuticals Total Revenue and its Long Term Debt accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy Vertex Stock please use our
How to Invest in Vertex Pharmaceuticals guide.
Total Revenue vs Long Term Debt
Total Revenue vs Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Vertex Pharmaceuticals Total Revenue account and
Long Term Debt. At this time, the significance of the direction appears to have no relationship.
The correlation between Vertex Pharmaceuticals' Total Revenue and Long Term Debt is 0.02. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Vertex Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Vertex Pharmaceuticals' Total Revenue and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Vertex Pharmaceuticals are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Total Revenue i.e., Vertex Pharmaceuticals' Total Revenue and Long Term Debt go up and down completely randomly.
Correlation Coefficient | 0.02 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Total Revenue
Total revenue comprises all receipts Vertex Pharmaceuticals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.
Long Term Debt
Long-term debt is a debt that Vertex Pharmaceuticals has held for over one year. Long-term debt appears on Vertex Pharmaceuticals balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Vertex Pharmaceuticals balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Most indicators from Vertex Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vertex Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy Vertex Stock please use our
How to Invest in Vertex Pharmaceuticals guide.At this time, Vertex Pharmaceuticals'
Selling General Administrative is fairly stable compared to the past year.
Tax Provision is likely to rise to about 798.2
M in 2024, whereas
Discontinued Operations is likely to drop (861.8
K) in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) |
Gross Profit | 6.7B | 7.9B | 8.6B | 9.0B | Total Revenue | 7.6B | 8.9B | 9.9B | 10.4B |
Vertex Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Vertex Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vertex Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to
measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.